Overview
- 12 inspections across 12 sites are on record.
- 36 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-05.
At a glance
Inspections
12
Sites
12
Observations
36
Career since
Sep 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| White Pineapple Corporation | 5 May 2026 | Human Drugs | |
| CoreRX Inc. | 26 Feb 2026 | Human Drugs | On file |
| Catalent Pharma Solutions, LLC | 30 Jan 2026 | Human Drugs | On file |
| Ecolab LLC | 5 Dec 2025 | Human Drugs | On file |
| Actavis Laboratories FL, Inc. | 18 Nov 2025 | Human Drugs | On file |
Sites inspected
White Pineapple CorporationSalisbury, United States1 insp.
CoreRX Inc.Clearwater, United States1 insp.
Catalent Pharma Solutions, LLCSaint Petersburg, United States1 insp.
Ecolab LLCGreensboro, United States1 insp.
Actavis Laboratories FL, Inc.Davie, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicole E Knowlton3 shared
Kayla V Sprague2 shared
Sonya M Edmonds2 shared
Damaris Y Hernandez1 shared
Seneca D Toms1 shared
Anthony J Donato1 shared
Saundrea A Munroe1 shared
Joanne E King1 shared
Veronica Fuentes1 shared
Cassidy W Criss1 shared
Full investigator report
Get the verbatim findings behind Tammy T Brown's 36 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site